Industry Expertise

Life Sciences

With the race to develop novel therapies and the growing complexity of biologics, pharma and biotech R&D faces mounting pressure to accelerate discovery, streamline development, and deliver life-changing treatments to patients faster than ever.

AI-Driven Drug Discovery & Development

Traditionally, the process of developing new drugs has been complex, costly, and slow, with the average time of getting a new drug from discovery to market being 12+ years. Life sciences companies are now investing heavily in artificial intelligence—and for good reason. Pharmaceutical and biotech R&D labs that leverage AI and machine learning are accelerating discovery and getting to clinical trials faster. However, many companies today are still entrenched in traditional methods of scientific research. Enthought helps pharmaceutical companies and CROs of all sizes harness the power of AI to expedite drug discovery and development, all centered around their unique IP. 
cell-culture

Domain Expertise

Purpose-Built Digital Solutions
for Pharma & Biotech
Schedule a Free Consultation
Trusted by Energy, Pharma and Biotech Companies Around the World
1 2 3 4 5 6 7 8 9 10 11 12 13 14 16 15 17 18 19 20 21 22 23 24

Insights & Resources
More Resources
The R&D Leader's Playbook for Agentic AI Success

This article references topics presented by Michael Connell, EdD during our recent webinar, Making Sense of Agentic AI:...
Concurrent Materials Design, Accelerated by AI

This article references topics presented by Dr. Michael Heiber at Enthought’s 2025 R&D Innovation Summit in Tokyo. Link...
6 Predictions: How AI Will Transform Scientific R&D In The Next Decade

This article was originally published on Forbes and can be found here. By Michael Connell, EdD | Chief Operating...

Ready to Take the Next Step?

Whether you need to get your R&D organization AI-ready or are ready to capitalize on advanced AI, Enthought can help.
Schedule a Free Consultation